Studies also showed that FAS is highly expressed in lung and prostate cancers and that FAS expression is an indicator of poor prognosis in breast and prostate cancer (3-5).

Conclusions: the blood flow detection by CDFI and the MVD, PCNA expression can effectively reflect angiogenesis in prostate cancer, will help to clinical therapy planning and predict prognosis.

Conclusion Detection of CD147 would contribute to understand the malignant degree of prostate cancer and evaluate it's prognosis. It has a guided value for establishing the therapeutic project.